ArticleGynecologic oncology reports2025
Growing teratoma syndrome in a chemotherapy naïve patient.
Article in Gynecologic oncology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pediatric malignant testicular germ cell tumors: a developmental and comparative perspective.Diagnostic pathology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Growing Teratoma Syndrome (GTS) is an exceptionally rare condition primarily observed in patients diagnosed with malignant germ cell tumors. It is characterized by the development of enlarging masses during or following the completion of appropriate chemotherapy, with normalization of previously elevated serum tumor markers, and a final pathologic assessment of the masses reveals benign mature teratomatous elements. The underlying mechanism of the benign teratomatous growth remains unclear. Multiple potential routes of dissemination have been proposed, with the peritoneum being the most reported site of metastasis. In this report, we present the case of an adolescent female patient diagnosed with an ovarian grade 1 immature teratoma, who developed disseminated peritoneal and mesenteric implants shortly after her initial surgery. The pathologic review of the implants demonstrated only mature teratomatous elements. Uniquely, the masses were identified in a chemotherapy naïve patient.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.